emeis Société anonyme Past Earnings Performance
Past criteria checks 2/6
emeis Société anonyme's earnings have been declining at an average annual rate of -25%, while the Healthcare industry saw earnings growing at 31.3% annually. Revenues have been growing at an average rate of 8.5% per year. emeis Société anonyme's return on equity is 76.3%, and it has net margins of 27%.
Key information
-25.0%
Earnings growth rate
-51.7%
EPS growth rate
| Healthcare Industry Growth | 12.6% |
| Revenue growth rate | 8.5% |
| Return on equity | 76.3% |
| Net Margin | 27.0% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How emeis Société anonyme makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 5,430 | 1,469 | 0 | 0 |
| 31 Mar 24 | 5,314 | 1,412 | 0 | 0 |
| 31 Dec 23 | 5,198 | 1,355 | 0 | 0 |
| 30 Sep 23 | 5,062 | -1,387 | 0 | 0 |
| 30 Jun 23 | 4,926 | -4,128 | 0 | 0 |
| 31 Mar 23 | 4,803 | -4,078 | 0 | 0 |
| 31 Dec 22 | 4,681 | -4,027 | 0 | 0 |
| 30 Sep 22 | 4,602 | -2,167 | 0 | 0 |
| 30 Jun 22 | 4,524 | -307 | 0 | 0 |
| 31 Mar 22 | 4,411 | -121 | 0 | 0 |
| 31 Dec 21 | 4,299 | 65 | 0 | 0 |
| 30 Sep 21 | 4,193 | 127 | 0 | 0 |
| 30 Jun 21 | 4,088 | 189 | 0 | 0 |
| 31 Mar 21 | 4,005 | 175 | 0 | 0 |
| 31 Dec 20 | 3,922 | 160 | 0 | 0 |
| 30 Sep 20 | 3,863 | 176 | 0 | 0 |
| 30 Jun 20 | 3,804 | 192 | 0 | 0 |
| 31 Mar 20 | 3,772 | 213 | 0 | 0 |
| 31 Dec 19 | 3,740 | 234 | 0 | 0 |
| 30 Sep 19 | 3,661 | 231 | 0 | 0 |
| 30 Jun 19 | 3,581 | 227 | 0 | 0 |
| 31 Mar 19 | 3,501 | 224 | 0 | 0 |
| 31 Dec 18 | 3,420 | 220 | 0 | 0 |
| 30 Sep 18 | 3,356 | 230 | 0 | 0 |
| 30 Jun 18 | 3,292 | 239 | 0 | 0 |
| 31 Mar 18 | 3,215 | 164 | 0 | 0 |
| 31 Dec 17 | 3,138 | 90 | 0 | 0 |
| 30 Sep 17 | 3,062 | 133 | 0 | 0 |
| 30 Jun 17 | 2,986 | 176 | 0 | 0 |
| 31 Mar 17 | 2,914 | 235 | 0 | 0 |
| 31 Dec 16 | 2,841 | 294 | 0 | 0 |
| 30 Sep 16 | 2,745 | 220 | 0 | 0 |
| 30 Jun 16 | 2,650 | 147 | 0 | 0 |
| 31 Mar 16 | 2,521 | 137 | 0 | 0 |
| 31 Dec 15 | 2,392 | 127 | 0 | 0 |
| 30 Sep 15 | 2,286 | 128 | 0 | 0 |
| 30 Jun 15 | 2,180 | 130 | 0 | 0 |
| 31 Mar 15 | 2,064 | 126 | 0 | 0 |
| 31 Dec 14 | 1,949 | 121 | 0 | 0 |
| 30 Sep 14 | 1,832 | 112 | 0 | 0 |
| 30 Jun 14 | 1,716 | 103 | 0 | 0 |
| 31 Mar 14 | 1,662 | 108 | 0 | 0 |
| 31 Dec 13 | 1,608 | 114 | 0 | 0 |
Quality Earnings: EMEISP has a high level of non-cash earnings.
Growing Profit Margin: EMEISP became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EMEISP has become profitable over the past 5 years, growing earnings by -25% per year.
Accelerating Growth: EMEISP has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: EMEISP has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (13.6%).
Return on Equity
High ROE: Whilst EMEISP's Return on Equity (76.34%) is outstanding, this metric is skewed due to their high level of debt.